MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Descriptive case studies of patients in their fifth consecutive year of treatment with ND0612

    A. Espay, A. Ellenbogen, T. Gurevich, R. Case, L. Adar, T. Yardeni, L. Salin (Cincinnati, USA)

    Objective: To describe the long-term experience of three individual patients receiving subcutaneous (SC) levodopa/carbidopa infusion with ND0612 in an open-label clinical safety study. Background: ND0612…
  • 2022 International Congress

    Temporal Dynamic Alterations of Regional Homogeneity in Parkinson’s disease: A Resting-State fMRI Study

    T. Yuan, L. Kai, S. Wen (Beijing, China)

    Objective: We aimed to test the differences of dynamic regional homogeneity (dReHo) between PD patients and healthy controls (HCs), and explore whether dReHo can be…
  • 2022 International Congress

    GPi-DBS induced brain metabolic activation in cervical dystonia

    EA. Honkanen, J. Korpela, E. Pekkonen, J. Aaltonen, M. Koivu, O. Eskola, H. Eldebakey, J. Volkmann, V. Kaasinen, MM. Reich, J. Joutsa (Turku, Finland)

    Objective: To investigate the effects of GPi-DBS on brain glucose metabolism locally at the stimulation site and across the whole brain in patients with cervical…
  • 2022 International Congress

    Long-term Safety of Medical Cannabis in Parkinson’s disease: a retrospective case-control study

    T. Goldberg, Y. Redlich, T. Fay-Karmon, S. Hassin-Baer, S. Anis (Tel Aviv, Israel)

    Objective: This study aims to evaluate the effects of long-term treatment with medical cannabis (MC) on the course of Parkinson’s disease (PD), with a focus…
  • 2022 International Congress

    Psychometric characteristics of the Neuropsychiatric Fluctuation Scale

    E. Schmitt, B. Debu, A. Kistner, A. Castrioto, V. Fraix, M. Bouvard, E. Moro (grenoble, France)

    Objective: To evaluate the psychometric properties of the Neuropsychiatric fluctuation scale (NFS) for Parkinson’s disease (PD). Background: Neuropsychiatric fluctuations (NpsyF) in PD are frequent and…
  • 2022 International Congress

    Sex differences in vascular risk factors for Parkinson’s disease

    K. Tsutsumi, E. Shah, A. Siddiqui, I. Attaripour (Orange, USA)

    Objective: Our aim is to illustrate the incidence of vascular risk factors (VRF) in a cohort of patients with confirmed Parkinson's disease (PD) and characterize…
  • 2022 International Congress

    Audit of dysphagia care provided to Parkinson’s patients during acute hospital admission

    M. Khwaja, G. Desai, J. Murphy, A. Chatterjee (Reading, United Kingdom)

    Objective: To evaluate dysphagia recognition and management in Parkinson’s patients admitted to Royal Berkshire Hospital (RBH),Reading,UK according to National Confidential Enquiry into Patient Outcome and…
  • 2022 International Congress

    CLINICAL AND GENEOLOGICAL FEATURES OF PARKINSON’S DISEASE

    S. Kuranbaeva, S. Kalandarova, A. Umarov, G. Goyibova (Tashkent, Uzbekistan)

    Objective: The initial purpose of the work is to study the clinical and genealogical features of Parkinson's disease. Background: Currently, clinical genetics has a number…
  • 2022 International Congress

    Isolated ZIC4 antibody associated paraneoplastic cerebellar degeneration

    A. Agarwal, A. Garg, A. Srivastava (New Delhi, India)

    Objective: Anti-ZIC4 antibodies have recently been associated with paraneoplastic cerebellar degeneration (PCD) and are usually associated with small cell carcinoma lung. However, most of the…
  • 2022 International Congress

    Blood biomarkers and their association with non-motor symptoms in early Parkinson’s Disease

    J. Kaur, S. Ng, N. Chia, X. Deng, J. Tan, X. Choi, D. Heng, Z. Xu, K. Tay, W. Au, A. Ng, E. Tan, L. Tan (central, Singapore)

    Objective: To identify if baseline blood biomarkers are associated with non-motor symptoms in early PD. Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder with…
  • « Previous Page
  • 1
  • …
  • 607
  • 608
  • 609
  • 610
  • 611
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley